Literature DB >> 30075863

A Status Report on FDA Approval of Medical Devices Containing Nanostructured Materials.

A-Andrew D Jones1, Gujie Mi2, Thomas J Webster3.   

Abstract

Commercialization has been slow since the FDA approved a medical device containing nanomaterials in 1980. In 2017, the FDA released draft guidance to accelerate approval. We highlight here that geographical and structural separation of researchers, manufacturers, and clinical servicers may slow commercialization more than FDA approval.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Keywords:  commercialization; implanted medical device; nanomaterials

Mesh：

Year:  2018        PMID： 30075863     DOI： 10.1016/j.tibtech.2018.06.003

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN： 0167-7799            Impact factor:   19.536


  10 in total

1.  Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies.

Authors:  Vanna Sanna; Mario Sechi
Journal:  ACS Med Chem Lett       Date:  2020-04-02       Impact factor: 4.345

Review 2.  Emerging Standards and Analytical Science for Nanoenabled Medical Products.

Authors:  Bryant C Nelson; Caterina Minelli; Shareen H Doak; Matthias Roesslein
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2020-02-21       Impact factor: 10.745

3.  Whither Magnetic Hyperthermia? A Tentative Roadmap.

Authors:  Irene Rubia-Rodríguez; Antonio Santana-Otero; Simo Spassov; Etelka Tombácz; Christer Johansson; Patricia De La Presa; Francisco J Teran; María Del Puerto Morales; Sabino Veintemillas-Verdaguer; Nguyen T K Thanh; Maximilian O Besenhard; Claire Wilhelm; Florence Gazeau; Quentin Harmer; Eric Mayes; Bella B Manshian; Stefaan J Soenen; Yuanyu Gu; Ángel Millán; Eleni K Efthimiadou; Jeff Gaudet; Patrick Goodwill; James Mansfield; Uwe Steinhoff; James Wells; Frank Wiekhorst; Daniel Ortega
Journal:  Materials (Basel)       Date:  2021-02-03       Impact factor: 3.623

Review 4.  Bio-Functional Textiles: Combining Pharmaceutical Nanocarriers with Fibrous Materials for Innovative Dermatological Therapies.

Authors:  Daniele Massella; Monica Argenziano; Ada Ferri; Jinping Guan; Stéphane Giraud; Roberta Cavalli; Antonello A Barresi; Fabien Salaün
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

Review 5.  Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.

Authors:  Nura A Mohamed; Isra Marei; Sergio Crovella; Haissam Abou-Saleh
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

6.  Importance of Standardizing Analytical Characterization Methodology for Improved Reliability of the Nanomedicine Literature.

Authors:  Shahriar Sharifi; Nouf N Mahmoud; Elizabeth Voke; Markita P Landry; Morteza Mahmoudi
Journal:  Nanomicro Lett       Date:  2022-08-20

7.  Inorganic Nanomaterial-Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities.

Authors:  Guanyou Lin; Richard A Revia; Miqin Zhang
Journal:  Adv Funct Mater       Date:  2020-10-13       Impact factor: 18.808

Review 8.  Recent Developments in Nanotechnology for Detection and Control of Aedes aegypti-Borne Diseases.

Authors:  Estefânia Vangelie Ramos Campos; Jhones Luiz de Oliveira; Daniele Carvalho Abrantes; Carolina Barbára Rogério; Carolina Bueno; Vanessa Regina Miranda; Renata Aparecida Monteiro; Leonardo Fernandes Fraceto
Journal:  Front Bioeng Biotechnol       Date:  2020-02-20

Review 9.  An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market.

Authors:  Anaida Kad; Archit Pundir; Shailendra Kumar Arya; Neha Bhardwaj; Madhu Khatri
Journal:  J Pharm Innov       Date:  2020-09-21       Impact factor: 2.538

Review 10.  Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.

Authors:  Joydeb Majumder; Tamara Minko
Journal:  Adv Ther (Weinh)       Date:  2020-10-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.